National Fungal Education and Response Readiness Network - A national initiative to strengthen education, awareness, communication, and response readiness for serious fungal disease - MyCARE Foundation proposes the National Fungal Education and Response Readiness Network, a five-year cooperative agreement to strengthen U.S. education, communication, training, dissemination, and response readiness for serious fungal diseases. The project aligns with CDC-RFA-CK-26-0107 and includes Components 1–4: infrastructure and capacity; emerging pathogens; antimicrobial resistance and healthcare-associated infections; and outbreak response. Fungal diseases are a growing, underrecognized threat, costing an estimated $19.4 billion annually and causing over 133,000 hospitalizations, 13.4 million outpatient visits, and 7,000 deaths. Symptoms often mimic other conditions, leading to delayed diagnosis, inappropriate treatment, increased costs, and patient confusion. Emerging threats, shifting geography, healthcare-associated infections, resistance, and misinformation require coordinated national education to translate CDC guidance and clinical expertise into practical tools. The project focuses on education, communication, training, dissemination, capacity building, and evaluation. It excludes surveillance, specimen handling, clinical care, and research. In Year 1, MyCARE will establish governance, partnerships, advisory and review structures, conduct a national needs and gap analysis, update digital platforms, launch two CME activities, deliver digital educational assets for various patient, public and provider audiences, and build rapid-response education capacity. The first CME will address recognition of coccidioidomycosis, evaluation of pneumonia, testing, diagnostic delay, and communication. The second CME will focus on Candida auris for front-line providers including identification, prevention, stewardship, and care coordination. MyCARE will engage early-career professionals and patient advocates as contributors and partners, thus growing the future workforce. Implementation will use a hub-and-spoke model with Washington University in St Louis, the Mycoses Study Group Education & Research Consortium, Coccidioidomycosis Study Group, International Pediatric Fungal Network, Terranova Medica, and broader partners across healthcare and community sectors. Outcomes include increased capacity, expanded education reach, improved clinician performance, enhanced public literacy, stronger facility readiness, and improved national response. The Network will strengthen recognition, communication, and preparedness across U.S. communities and care settings.